NYSE ARCA | ETF
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index.
The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business.
GLP-1 agonists seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss.
The fund is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 15.61% |
NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 14.90% |
NVO | Novo Nordisk A/S | Healthcare | Drug Manufacturers - General | 13.93% |
AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 5.90% |
4519 | Chugai Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - General | 5.11% |
WST | West Pharmaceutical Services Inc | Healthcare | Medical Instruments & Supplies | 5.10% |
1801 | Innovent Biologics Inc | Healthcare | Biotechnology | 5.01% |
TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 4.93% |
MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.79% |
AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.71% |
AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 4.69% |
MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.69% |
ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 4.67% |
TEVA | Teva Pharma Industries Ltd ADR | Healthcare | Drug Manufacturers - Specialty & Generic | 4.63% |
PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 4.60% |
4901 | Fujifilm Holdings Corp. | Industrials | Conglomerates | 4.17% |
HIMS | Hims Hers Health Inc | Consumer Defensive | Household & Personal Products | 3.95% |
0O14 | MERCK Kommanditgesellschaft auf Aktien | 3.54% | ||
4188 | Mitsubishi Chemical Holdings Corp | Basic Materials | Specialty Chemicals | 3.45% |
ZEAL | Zealand Pharma A/S | Healthcare | Biotechnology | 2.34% |